🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ectopic pregnancy is an important cause of maternal morbidity and occasiona...
Status
Completed
Location
CHA Gangnam Medical Center
Start Date
2013-05
Trial ID
NCT01855568
Treatments Being Tested
This is a randomized controlled trial to compare three currently available ...
Status
Completed
Location
University of California San Francisco
Start Date
2014-07-25
Trial ID
NCT02152696
Treatments Being Tested
RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-10-24
Trial ID
NCT00045305
This is a placebo controlled randomised clinical trial.Patients attending Y...
Status
Completed
Location
Chapel Allerton Hospital
Start Date
2006-09
Trial ID
NCT01308255
Treatments Being Tested
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
The purpose of this study is to determine the safety and optimal dosing of ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2002-06
Trial ID
NCT00136435
The purpose of this study is to determine the safety and effectiveness of a...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-04
Trial ID
NCT00476190
HEM-iSMART is a master protocol which investigates multiple investigational...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2025-10-01
Trial ID
NCT05751044
Treatments Being Tested
With increasing survival rates in pediatric oncology, reports of long-term ...
Status
Recruiting
Location
Department of Pediatrics and Adolescent Medicine
Start Date
2025-11-19
Trial ID
NCT07313878
QUESTIONS AND OBJECTIVES OF ALL-MB 2015 STUDY 1. Will the new risk group s...
Status
Unknown
Location
prof. R.O.Eolyan Hematology Center
Start Date
2015-11
Trial ID
NCT03390387